Preparation process for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]benzoic acid

The present invention relates to preparation processes for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors MOON, YOUNGOON, HWANG, PETER SEONGWOO, ALMSTEAD, NEIL G
Format Patent
LanguageEnglish
Polish
Published 30.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to preparation processes for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay.
Bibliography:Application Number: PL20120185448T